LONDON and PHILADELPHIA, October 1 /PRNewswire/ --

- Each Report uses Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments on the International Pharmaceutical Pipeline

Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, has announced the availability of three Pharma Matters reports covering the time period April - June 2008. The quarterly Pharma Matters reports cover all aspects of the pharmaceutical pipeline, leveraging strategic intelligence and competitive analysis from Thomson Pharma(R), Newport Horizon Premium(TM) and the Thomson Messaging Mapping System(SM).

EDMONTON, Canada, October 1 /PRNewswire/ -- Control-See, a leader in alarm notification software, has chosen to standardize on MatrikonOPC technology for all of its data connectivity needs. "To receive secure and reliable alarm notification data we chose MatrikonOPC as our data connectivity provider due to their reputation as the industry standard for providing reliable critical data." said Michael Meirovitz, CEO of Control-See. MatrikonOPC is proud with the partnership and welcomes Control-See to its Reseller Partner Program. Control See will act as a reseller and systems integrator for MatrikonOPC products in Israel and Middle-East regions.

HERNDON, Virginia and SUNNYVALE, California, October 1 /PRNewswire/ --

- Spirent SR5500 Test Solution Contributes to Successful Rollout of WiMAX Services in North America

WiMAX World 2008 Spirent Booth # 63 -- Spirent Communications plc (LSE: SPT), a global provider of performance analysis and service management solutions, today announced that it has been selected by AT4 wireless to provide RF channel emulation capability to AT4 wireless' WiMAX interoperability lab. The lab will use Spirent SR5500 Wireless Channel Emulators to test the interoperability between commercial WiMAX infrastructure and WiMAX mobile devices.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080909/CLTU016LOGO )

LONDON, October 1 /PRNewswire/ -- Excalibur, the international investment house specialising in medical sciences, said today 'transforming' deals could still be achieved in the UK biotech sector despite the most severe market conditions.

Excalibur, founded by Professor Sir Christopher Evans and a development of Merlin Biosciences, was instrumental in securing important funding to enable York Pharma plc, the specialist dermatology company, to make a significant product acquisition which will propel the company into profit and generate significant revenues.

HALIFAX, Canada, October 1 /PRNewswire/ -- ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious disease vaccine models. The results of this research will be presented October 4th at the Ehrlich II conference in Germany. Collaborators from the University of Miami will also be reporting on the capabilities of IVT's depot formulations for delivery of DNA and SiRNA in vivo.

LONDON, October 1 /PRNewswire/ -- Thousands of NHS employees are being asked to take industrial action in a pay protest ballot next month by Unite, the largest union in the country.

Unite will be asking its members whether they are prepared to take industrial action, including strike action, in the ballot which commences on 28 October.

After the ballot closes on 12 November, Unite will have a 28-day 'window' to take action that its members have voted for.

Unite's ballot is underpinned by a 95% rejection by its members of the Government's unilaterally imposed three-year pay deal, worth in total 7.99% - barely half the current rate of inflation. It is further reinforced by a 75% vote in favour of an industrial action ballot.